Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Occupational coccidioidomycosis surveillance and recent outbreaks in California.

de Perio MA, Materna BL, Sondermeyer Cooksey GL, Vugia DJ, Su CP, Luckhaupt SE, McNary J, Wilken JA.

Med Mycol. 2019 Feb 1;57(Supplement_1):S41-S45. doi: 10.1093/mmy/myy031. Review.

PMID:
30690596
2.

Knowledge, Attitudes, and Practices among Members of Households Actively Monitored or Quarantined to Prevent Transmission of Ebola Virus Disease - Margibi County, Liberia: February-March 2015.

Wilken JA, Pordell P, Goode B, Jarteh R, Miller Z, Saygar BG, Maximore L, Borbor WM, Carmue M, Walker GW, Yeiah A.

Prehosp Disaster Med. 2017 Dec;32(6):673-678. doi: 10.1017/S1049023X17006720. Epub 2017 Jul 27.

PMID:
28748776
3.

Dust Exposure and Coccidioidomycosis Prevention Among Solar Power Farm Construction Workers in California.

Sondermeyer Cooksey GL, Wilken JA, McNary J, Gilliss D, Shusterman D, Materna BL, Vugia DJ.

Am J Public Health. 2017 Aug;107(8):1296-1303. doi: 10.2105/AJPH.2017.303820. Epub 2017 Jun 22.

4.

Inhalational Chlorine Injuries at Public Aquatic Venues - California, 2008-2015.

Wilken JA, DiMaggio M, Kaufmann M, O'Connor K, Smorodinsky S, Armatas C, Barreau T, Kreutzer R, Ancheta L.

MMWR Morb Mortal Wkly Rep. 2017 May 19;66(19):498-501. doi: 10.15585/mmwr.mm6619a3.

5.

Physical, Mental, and Financial Impacts From Drought in Two California Counties, 2015.

Barreau T, Conway D, Haught K, Jackson R, Kreutzer R, Lockman A, Minnick S, Roisman R, Rozell D, Smorodinsky S, Tafoya D, Wilken JA.

Am J Public Health. 2017 May;107(5):783-790. doi: 10.2105/AJPH.2017.303695. Epub 2017 Mar 21.

6.

Occupational HIV Transmission Among Male Adult Film Performers - Multiple States, 2014.

Wilken JA, Ried C, Rickett P, Arno JN, Mendez Y, Harrison RJ, Wohlfeiler D, Bauer HM, Joyce MP, Switzer WM, Heneine W, Shankar A, Mark KE.

MMWR Morb Mortal Wkly Rep. 2016 Feb 12;65(5):110-4. doi: 10.15585/mmwr.mm6505a3.

7.

Thyroid Hormones and Timing of Pubertal Onset in a Longitudinal Cohort of Females, Northern California, 2006-11.

Wilken JA, Greenspan LC, Kushi LH, Voss RW, Windham GC.

Paediatr Perinat Epidemiol. 2016 May;30(3):285-93. doi: 10.1111/ppe.12280. Epub 2016 Feb 5.

PMID:
26849015
8.

Coccidioidomycosis among Workers Constructing Solar Power Farms, California, USA, 2011-2014.

Wilken JA, Sondermeyer G, Shusterman D, McNary J, Vugia DJ, McDowell A, Borenstein P, Gilliss D, Ancock B, Prudhomme J, Gold D, Windham GC, Lee L, Materna BL.

Emerg Infect Dis. 2015 Nov;21(11):1997-2005. doi: 10.3201/eid2111.150129.

9.

Injuries and Traumatic Psychological Exposures Associated with the South Napa Earthquake - California, 2014.

Attfield KR, Dobson CB, Henn JB, Acosta M, Smorodinsky S, Wilken JA, Barreau T, Schreiber M, Windham GC, Materna BL, Roisman R.

MMWR Morb Mortal Wkly Rep. 2015 Sep 11;64(35):975-8. doi: 10.15585/mmwr.mm6435a4.

10.

Exposures and symptoms among workers after an offsite train derailment and vinyl chloride release.

Wilken JA, Graziano L, Vaouli E, Markiewicz K, Helverson R, Brinker K, Shumate AM, Duncan MA.

Am J Disaster Med. 2015 Spring;10(2):153-65. doi: 10.5055/ajdm.2015.0198.

11.

Assessing prevention measures and Sin Nombre hantavirus seroprevalence among workers at Yosemite National Park.

Wilken JA, Jackson R, Materna BL, Windham GC, Enge B, Messenger S, Xia D, Knust B, Buttke D, Roisman R; Yosemite Hantavirus Outbreak Investigation Team.

Am J Ind Med. 2015 Jun;58(6):658-67. doi: 10.1002/ajim.22445. Epub 2015 May 5.

PMID:
25943457
12.

Coccidioidomycosis among cast and crew members at an outdoor television filming event--California, 2012.

Wilken JA, Marquez P, Terashita D, McNary J, Windham G, Materna B; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Apr 18;63(15):321-4.

13.

Shedding of soluble epidermal growth factor receptor (sEGFR) is mediated by a metalloprotease/fibronectin/integrin axis and inhibited by cetuximab.

Wilken JA, Perez-Torres M, Nieves-Alicea R, Cora EM, Christensen TA, Baron AT, Maihle NJ.

Biochemistry. 2013 Jul 2;52(26):4531-40. doi: 10.1021/bi400437d. Epub 2013 Jun 21.

PMID:
23731208
14.

A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group study.

Leslie KK, Sill MW, Fischer E, Darcy KM, Mannel RS, Tewari KS, Hanjani P, Wilken JA, Baron AT, Godwin AK, Schilder RJ, Singh M, Maihle NJ.

Gynecol Oncol. 2013 Jun;129(3):486-94. doi: 10.1016/j.ygyno.2013.02.019. Epub 2013 Feb 21.

15.

EGFR/HER-targeted therapeutics in ovarian cancer.

Wilken JA, Badri T, Cross S, Raji R, Santin AD, Schwartz P, Branscum AJ, Baron AT, Sakhitab AI, Maihle NJ.

Future Med Chem. 2012 Mar;4(4):447-69. doi: 10.4155/fmc.12.11. Review.

16.

The epidermal growth factor receptor conundrum.

Wilken JA, Baron AT, Maihle NJ.

Cancer. 2011 Jun 1;117(11):2358-60. doi: 10.1002/cncr.25805. Epub 2010 Dec 14. No abstract available.

17.

Identification of immunoreactive regions of homology between soluble epidermal growth factor receptor and α5-integrin.

Wilken JA, Baron AT, Foty RA, McCormick DJ, Maihle NJ.

Biochemistry. 2011 May 24;50(20):4309-21. doi: 10.1021/bi200126j. Epub 2011 Apr 27.

18.

The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research.

Xu L, Wang SS, Healey MA, Faupel-Badger JM, Wilken JA, Battaglia T, Szabo E, Mao JT, Bergan RC.

Cancer Prev Res (Phila). 2011 Apr;4(4):616-21. doi: 10.1158/1940-6207.CAPR-11-0018.

19.

Primary trastuzumab resistance: new tricks for an old drug.

Wilken JA, Maihle NJ.

Ann N Y Acad Sci. 2010 Oct;1210:53-65. doi: 10.1111/j.1749-6632.2010.05782.x.

20.

EGFR isoforms and gene regulation in human endometrial cancer cells.

Albitar L, Pickett G, Morgan M, Wilken JA, Maihle NJ, Leslie KK.

Mol Cancer. 2010 Jun 25;9:166. doi: 10.1186/1476-4598-9-166.

21.

Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics.

Wilken JA, Webster KT, Maihle NJ.

J Ovarian Res. 2010 Mar 27;3:7. doi: 10.1186/1757-2215-3-7.

22.

Clinical implementation of soluble EGFR (sEGFR) as a theragnostic serum biomarker of breast, lung and ovarian cancer.

Baron AT, Wilken JA, Haggstrom DE, Goodrich ST, Maihle NJ.

IDrugs. 2009 May;12(5):302-8. Review.

PMID:
19431095
23.

Trastuzumab-induced HER reprogramming in "resistant" breast carcinoma cells.

Narayan M, Wilken JA, Harris LN, Baron AT, Kimbler KD, Maihle NJ.

Cancer Res. 2009 Mar 15;69(6):2191-4. doi: 10.1158/0008-5472.CAN-08-1056. Epub 2009 Mar 10.

24.

Prospective memory and the efficacy of a memory strategy in multiple sclerosis.

Kardiasmenos KS, Clawson DM, Wilken JA, Wallin MT.

Neuropsychology. 2008 Nov;22(6):746-54. doi: 10.1037/a0013211.

PMID:
18999348
25.

Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer.

Lafky JM, Wilken JA, Baron AT, Maihle NJ.

Biochim Biophys Acta. 2008 Apr;1785(2):232-65. doi: 10.1016/j.bbcan.2008.01.001. Epub 2008 Feb 7. Review.

PMID:
18291115
26.

Recognizing and treating common psychiatric disorders in multiple sclerosis.

Wilken JA, Sullivan C.

Neurologist. 2007 Nov;13(6):343-54. Review.

PMID:
18090712
27.
28.

Initial construct validation of frequently employed ANAM measures through structural equation modeling.

Short P, Cernich A, Wilken JA, Kane RL.

Arch Clin Neuropsychol. 2007 Feb;22 Suppl 1:S63-77. Epub 2006 Dec 4. Review.

29.

The use of ANAM to assess the side-effect profiles and efficacy of medication.

Wilken JA, Sullivan CL, Lewandowski A, Kane RL.

Arch Clin Neuropsychol. 2007 Feb;22 Suppl 1:S127-33. Epub 2006 Nov 20. Review.

30.

Cognitive dysfunction in multiple sclerosis: Assessment, imaging, and risk factors.

Wallin MT, Wilken JA, Kane R.

J Rehabil Res Dev. 2006 Jan-Feb;43(1):63-72. Review.

31.

Depression and multiple sclerosis: Review of a lethal combination.

Wallin MT, Wilken JA, Turner AP, Williams RM, Kane R.

J Rehabil Res Dev. 2006 Jan-Feb;43(1):45-62. Review.

32.

Desloratadine for allergic rhinitis.

Wilken JA, Daly AF, Sullivan CL, Kim H.

Expert Rev Clin Immunol. 2006 Mar;2(2):209-24. doi: 10.1586/1744666X.2.2.209.

PMID:
20477072
33.
34.

A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis.

Wilken JA, Kane RL, Ellis AK, Rafeiro E, Briscoe MP, Sullivan CL, Day JH.

Ann Allergy Asthma Immunol. 2003 Oct;91(4):375-85.

PMID:
14582817
35.

The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting multiple sclerosis.

Wilken JA, Kane R, Sullivan CL, Wallin M, Usiskin JB, Quig ME, Simsarian J, Saunders C, Crayton H, Mandler R, Kerr D, Reeves D, Fuchs K, Manning C, Keller M.

Mult Scler. 2003 Mar;9(2):119-27.

PMID:
12708806
36.

Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitis.

Wilken JA, Berkowitz R, Kane R.

Ann Allergy Asthma Immunol. 2002 Oct;89(4):372-80.

PMID:
12392381
37.

Comparison of chorionic gonadotropin expression in human and macaque (Macaca fascicularis) trophoblasts.

Wilken JA, Matsumoto K, Laughlin LS, Lasley BL, Bedows E.

Am J Primatol. 2002 Feb;56(2):89-97.

PMID:
11793416
38.

Functional contributions of noncysteine residues within the cystine knots of human chorionic gonadotropin subunits.

Darling RJ, Wilken JA, Miller-Lindholm AK, Urlacher TM, Ruddon RW, Sherman SA, Bedows E.

J Biol Chem. 2001 Apr 6;276(14):10692-9. Epub 2000 Dec 29.

39.

Intracellular folding pathway of the cystine knot-containing glycoprotein hormone alpha-subunit.

Darling RJ, Wilken JA, Ruddon RW, Bedows E.

Biochemistry. 2001 Jan 16;40(2):577-85.

PMID:
11148053
40.

Trait anxiety and prior exposure to non-stressful stimuli: effects on psychophysiological arousal and anxiety.

Wilken JA, Smith BD, Tola K, Mann M.

Int J Psychophysiol. 2000 Sep;37(3):233-42.

PMID:
10858569

Supplemental Content

Loading ...
Support Center